Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonist

Weier Qi, Simina M. Boca, Alessandro Boianelli, Monica Fredberg, Sara Lundqvist, Graeme Davies, Joss Field, Cheryl A. Brighton, Arjan Snijder, Pernilla Grundevik, Daniel Eckernäs, Annika Maria Träff, Magnus Polla, Daniel Pettersen, Sami Omar, Lars Hansen, David Janzén, Johanna Melin, Natalie van Zuydam, Jennifer Logue, Kristina Wallenius

Open source

DOI
10.1016/j.jpet.2025.103683
Published
2025-10
Container
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jpet.2025.103683,
  title = {Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonist},
  author = {Weier Qi and Simina M. Boca and Alessandro Boianelli and Monica Fredberg and Sara Lundqvist and Graeme Davies and Joss Field and Cheryl A. Brighton and Arjan Snijder and Pernilla Grundevik and Daniel Eckernäs and Annika Maria Träff and Magnus Polla and Daniel Pettersen and Sami Omar and Lars Hansen and David Janzén and Johanna Melin and Natalie van Zuydam and Jennifer Logue and Kristina Wallenius},
  year = {2025},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  doi = {10.1016/j.jpet.2025.103683},
  url = {https://doi.org/10.1016/j.jpet.2025.103683}
}

RIS

TY  - JOUR
TI  - Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonist
AU  - Weier Qi
AU  - Simina M. Boca
AU  - Alessandro Boianelli
AU  - Monica Fredberg
AU  - Sara Lundqvist
AU  - Graeme Davies
AU  - Joss Field
AU  - Cheryl A. Brighton
AU  - Arjan Snijder
AU  - Pernilla Grundevik
AU  - Daniel Eckernäs
AU  - Annika Maria Träff
AU  - Magnus Polla
AU  - Daniel Pettersen
AU  - Sami Omar
AU  - Lars Hansen
AU  - David Janzén
AU  - Johanna Melin
AU  - Natalie van Zuydam
AU  - Jennifer Logue
AU  - Kristina Wallenius
PY  - 2025
JO  - The Journal of Pharmacology and Experimental Therapeutics
DO  - 10.1016/j.jpet.2025.103683
UR  - https://doi.org/10.1016/j.jpet.2025.103683
ER  - 

APA

Qi, W., Boca, S. M., Boianelli, A., Fredberg, M., Lundqvist, S., Davies, G., Field, J., Brighton, C. A., Snijder, A., Grundevik, P., Eckernäs, D., Träff, A. M., Polla, M., Pettersen, D., Omar, S., Hansen, L., Janzén, D., Melin, J., Zuydam, N. V., Logue, J., & Wallenius, K. (2025). Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonist. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/j.jpet.2025.103683

Source records